| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.5 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | -0.043 | 0.5 |